erianin and complestatin

erianin has been researched along with complestatin* in 1 studies

Other Studies

1 other study(ies) available for erianin and complestatin

ArticleYear
Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: synthesis, cytotoxicity and antitubulin activity.
    European journal of medicinal chemistry, 2012, Volume: 52

    A novel series of dihydronaphtalene, tetrahydronaphtalene and naphtalene derivatives as restricted analogues of isoCA-4 were designed, synthesized and evaluated for their anticancer properties. High cell growth inhibition against four tumour cell lines was observed at a nanomolar level with dihydronaphtalenes 1d, e and 1h, tetrahydronaphtalene 2c and naphtalene 3c. Structure-activity relationships are also considered. These compounds exhibited a significant inhibitory activity toward tubulin polymerization (IC(50) = 2-3 μM), comparable to that of isoCA-4. The effect of the lead compounds 1e and 2c on the cancer cells tested was associated with cell cycle arrest in the G(2)/M phase. Docking studies reveal that these compounds showed a binding mode similar to those observed with their non-constraint isoCA-4 and isoerianin congeners.

    Topics: Antineoplastic Agents; Benzene; Bibenzyls; Cell Line, Tumor; Chlorophenols; Humans; Models, Molecular; Molecular Conformation; Naphthalenes; Peptides, Cyclic; Phenol; Protein Multimerization; Protein Structure, Quaternary; Tubulin; Tubulin Modulators

2012